Olaflur

This classification denotes a cariostatic agent with the molecular formula C27H58N2O3.2FH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8NY9L8837D, chemically known as 2,2-((3-(2-hydroxyethyl) octadecylamino)propyl) iminodiethanol dihydrofluoride but generally known as olaflur, which bears US NIH Compound Identifier 23257. European Medicines Agency schedules Olaflur in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09425MIG. World Health Organization schedules olaflur in its Anatomical Therapeutic Chemical (ATC) Classification. OLAFLUR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule olaflur under HS 29221980 and SITC 51461. As of Q4 2014, OLAFLUR remains the US FDA Preferred Term for this commodity. SMILES: F.F.OCCN(CCCCCCCCCCCCCCCCCC)CCCN(CCO)CCO.